Medicine

Xiao Huan, Ran Chen, Lei Jin, Yuan Wang, Yafang Xu, Lei Yang, Caihua Xi, Jianming Zheng, L. Luo, Song Yang, Jianquan Shi, Yanping Liu, Zhe Ruan, Wanlong Wu, Wei Li, Yaoxian Yue, Yarong Li, Wenji Jia, Huahua Zhong, Chong Yan, Jie Song, Jianying Xi, S. Tan, Qilong Jiang, Zhangyu Zou, Chongbo Zhao, Sushan Luo

2026.1.27EUROPEAN JOURNAL OF NEUROLOGY

DOI: 10.1111/ene.70513

tlooto Summary

This prospective multicentre study aimed to evaluate 1‐year clinical outcomes after myasthenic crisis by evaluating 1‐year clinical outcomes after MC.

Abstract

Myasthenic crisis (MC) affects 10%–20% of myasthenia gravis patients and is life‐threatening with significant economic burden, yet its long‐term outcomes remain poorly understood. This prospective multicentre study aimed to evaluate 1‐year clinical outcomes after MC.

Citation format

HUAN, Xiao, et al. 1‐Year clinical outcome post‐myasthenic crisis: A multicenter prospective study in China. EUROPEAN JOURNAL OF NEUROLOGY, 2026, 33(2): e70513.